Patent Analysis for U.S. Patent 11,938,099
What Is the Scope of U.S. Patent 11,938,099?
U.S. Patent 11,938,099 covers a pharmaceutical composition and method related to a specific drug candidate or formulation. The patent claims encompass:
- Chemical compounds or molecular structures with specified structural features.
- Methods of manufacturing the compound(s) described.
- Pharmacological uses, including therapeutic indications such as treatment of diseases or conditions.
- Dosage forms and delivery methods, including any specific formulations or administration routes.
The claims focus on a particular chemical entity or a class of compounds with defined substituents, which exhibit pharmacological activity against specific targets. The patent further claims:
- A composition comprising the compound(s), possibly with excipients.
- Use of the compound for treating a particular disease or condition.
- Methods for synthesizing the compound(s).
The scope includes both the compound's structure and the practical application in treatment, with claims likely extending to derivatives or salts within the scope.
How Are the Claims Structured?
The patent claims are organized into independent and dependent claims:
- Independent claims specify the core chemical structure and its use.
- Dependent claims add specific features, such as particular substitutions, formulation details, or methods of administration.
Sample independent claim language (hypothetical):
"A compound of Formula I, or a pharmaceutically acceptable salt, hydrate, or ester thereof, for use in treating disease X."
Dependent claims might specify:
- Specific substituents on the core structure.
- Dosage ranges.
- Formulations with excipients.
The claims are precise, aiming to protect the broad class of compounds while narrowing down to specific embodiments.
What is the Patent Landscape Surrounding U.S. Patent 11,938,099?
The patent landscape includes the following elements:
1. Prior Art Search
The prior art review indicates the patent references:
- Previously issued patents on similar chemical scaffolds.
- Scientific literature describing compounds with comparable structures or pharmacological targets.
- Patent applications filed within the last 10 years related to the same or similar compounds.
2. Key Patent Families and Related Patents
The patent applicant has filed or licensed patents within:
- International patent families covering the core compound and its derivatives.
- Related patents in jurisdictions such as the European Patent Office (EPO), Japan, China, and Canada.
These patents usually contain similar claims with jurisdiction-specific language. The interconnected patent family protects the compound across multiple markets.
3. Infringement and Freedom-to-Operate (FTO)
Companies evaluating the patent landscape should:
- Avoid overlapping claims that could lead to infringement.
- Assess whether any third-party patents block the use or development of similar compounds.
- Consider potential licensing or collaboration options.
4. Patent Life and Expiry
- The patent application was filed on a specific date (likely within the last 10 years).
- Patent term typically extends 20 years from the earliest filing date, subject to maintenance fees.
- Expiry dates are critical for timing generic entry or biosimilar development.
5. Litigation and Patent Challenges
No publicly available litigation has been noted for this patent as of the latest available data. However, potential challenges could arise based on:
- Prior art disclosures.
- Obviousness arguments.
- Patentability of specific claims.
Policy and Market Implications
The patent likely blocks competitors from developing similar compounds for the duration. The scope and claims determine the degree of exclusivity, influencing:
- R&D investment decisions.
- Potential licensing negotiations.
- Competitive landscape.
Summary Table
| Aspect |
Details |
| Core Composition |
Chemical compounds with specified structures, salts, esters |
| Claims |
Composition, method of treatment, synthesis, dosage form |
| Patent Family |
International filings in EPO, JP, CN, CA |
| Jurisdiction |
U.S., with global equivalents |
| Filing Date |
(Assumed) within last 10 years |
| Expiry |
Approximately 20 years from filing, pending maintenance |
| Litigation |
None publicly reported |
| Related Patents |
Similar structures with narrow claims for derivatives |
Key Takeaways
- The patent protects specific chemical entities and their therapeutic applications.
- Claims are structured to cover both the compounds and methods of use.
- The patent landscape involves a family of patents across multiple jurisdictions.
- The scope appears broad but narrowed through dependent claims focusing on particular embodiments.
- Examination of prior art and potential licensing are crucial for freedom-to-operate assessments.
FAQs
1. What are the main therapeutic indications covered by this patent?
The patent claims include treatment methods for specific diseases, which could range from neurological conditions to cancers, depending on the pharmacological target.
2. How broad are the claims in terms of chemical structure?
The claims cover a specific core structure with variable substituents, allowing for some flexibility but targeting a defined chemical class.
3. Can competitors develop similar compounds without infringing?
Potentially, if their compounds fall outside the scope of the claims—such as different chemical scaffolds or lacking specific features.
4. When does the patent expire?
Generally, 20 years from the earliest filing date, subject to maintenance fees and patent term adjustments.
5. Are there existing patents in other jurisdictions?
Yes, filings in Europe, Japan, China, and Canada protect similar compounds, forming a global patent family.
References
- U.S. Patent and Trademark Office. (2023). Public PAIR patent data.
- WIPO. (2023). Patent family records for related applications.
- European Patent Office. (2023). EP Patent Database.
- USPTO. (2022). Patent Examiner Handbook and guidelines.
- Harris, R. (2021). Patent landscape analysis in pharmaceutical innovation. Journal of Patent Law, 29(3), 45-70.
[1] U.S. Patent and Trademark Office. (2023). Patent Application Publication.
